Advanced search
Publication Cover
Journal of Medical Economics Volume 21, 2018 - Issue 12
Submit an article Journal homepage
846
Views
4
CrossRef citations to date
0
Altmetric
Oncology

Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States

Mairead KearneyMerck KGaA, Darmstadt, Germany;
,
Katia ThokagevistkCreativ-Ceutical, Paris, France
,
Emmanuelle BoutmyMerck KGaA, Darmstadt, Germany;
&
Murtuza BharmalMerck KGaA, Darmstadt, Germany; Correspondence[email protected]
Pages 1159-1171 | Received 09 Jul 2018, Accepted 24 Aug 2018, Published online: 12 Sep 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Murtuza Bharmal, Mairead Kearney, Ying Zheng & Hemant Phatak. (2019) Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US. ClinicoEconomics and Outcomes Research 11, pages 349-359.
Read now

Articles from other publishers (3)

Roberto Palencia, Amrita Sandhu, Sarah Webb, Tom Blaikie & Murtuza Bharmal. (2021) Systematic literature review of current treatments for stage I–III Merkel cell carcinoma. Future Oncology 17:34, pages 4813-4822.
Crossref
Nicole M Zimmerman, David Ray, Nicole Princic, Meghan Moynihan, Callisia Clarke & Alexandria Phan. (2021) Exploration of machine learning techniques to examine the journey to neuroendocrine tumor diagnosis with real-world data. Future Oncology 17:24, pages 3217-3230.
Crossref
Sunandana Chandra, Ying Zheng, Shivani Pandya, Ting Yu, Mairead Kearney, Li Wang, Ruth Kim & Hemant Phatak. (2020) Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy. Future Oncology 16:31, pages 2521-2536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.